RENAL HYPERTENSIVE ANGIOPATHY - COMPARISON BETWEEN CHRONIC NO SUPPRESSION AND DOCA-SALT INTOXICATION

被引:0
|
作者
XU, YC
ARNAL, JF
HINGLAIS, N
APPAY, MD
LABOULANDINE, I
BARIETY, J
MICHEL, JB
机构
关键词
N-G-NITRO-L-ARGININE METHYL ESTER (L-NAME); PLASMA RENIN ACTIVITY; GLOMERULOSCLEROSIS; CYCLIC GMP; RENIN IMMUNOSTAINING;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
N-G-nitro-L-arginine methyl ester (L-NAME) and 11l-desoxycorticosterone plus salt intake (DOCA-salt) hypertensive rat models were compared to study the possible involvement of model-specific factors in the development of renal angiopathy and left ventricular hypertrophy (LVH). Blood pressure was measured in L-NAME, DOCA-salt hypertensive, and control Wistar rats, and the lesions of nephroangiosclerosis and left ventricular hypertrophy were evaluated after 7 weeks. Arterial wall cyclic guanosine monophosphate, plasma renin activity (PRA), and renal renin storage were assessed in parallel. For the same level of hypertension in the two models, the renal arterial fibrinoid necrotic lesions were significantly more frequent in L-NAME than in DOCA salt hypertensive rats. In DOCA-salt hypertensive rats, PRA was decreased and arterial cGMP increased compared to controls. In the L-NAME model, arterial cGMP decreased and PRA showed a bimodal distribution in this intermediate stage of hypertensive disease. LVH was observed in DOCA-salt rats and only in the L-NAME rats with a high level of PRA. There was a close correlation between the lesions of nephroangiosclerosis, left ventricular index, and plasma renin activity in L-NAME rats. We therefore suggest that the activation of the renin-angiotensin system participates specifically in the development of the second stage of hypertension during chronic blockade of NO synthase involving nephroangiosclerosis and LVH.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 7 条
  • [1] Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
    Bae, Eun Hui
    Kim, In Jin
    Ma, Seong Kwon
    Kim, Soo Wan
    HYPERTENSION RESEARCH, 2010, 33 (03) : 255 - 262
  • [2] Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
    Eun Hui Bae
    In Jin Kim
    Seong Kwon Ma
    Soo Wan Kim
    Hypertension Research, 2010, 33 : 255 - 262
  • [3] Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats
    Bae, Eun Hui
    Kim, In Jin
    Park, Jeong Woo
    Ma, Seong Kwon
    Lee, Jong Un
    Kim, Soo Wan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (04) : 1051 - 1059
  • [4] Renoprotective Effects of Sildenafil in DOCA-Salt Hypertensive Rats
    Bae, Eun Hui
    Kim, In Jin
    Joo, Soo Yeon
    Kim, Eun Young
    Kim, Chang Seong
    Choi, Joon Seok
    Ma, Seong Kwon
    Kim, Suhn Hee
    Lee, Jong Un
    Kim, Soo Wan
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01) : 248 - 257
  • [5] Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats
    Bae, Eun Hui
    Kim, In Jin
    Ma, Seong Kwon
    Kim, Soo Wan
    REGULATORY PEPTIDES, 2009, 157 (1-3) : 76 - 83
  • [6] ROLE OF ENDOGENOUS ATRIAL-NATRIURETIC-PEPTIDE IN DOCA-SALT HYPERTENSIVE RATS - EFFECTS OF A NOVEL NONPEPTIDE ANTAGONIST FOR ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR
    HIRATA, Y
    MATSUOKA, H
    SUZUKI, E
    HAYAKAWA, H
    SUGIMOTO, T
    MATSUDA, Y
    MORISHITA, Y
    KANGAWA, K
    MINAMINO, N
    MATSUO, H
    SUGIMOTO, T
    CIRCULATION, 1993, 87 (02) : 554 - 561
  • [7] DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains
    Erdely, Aaron
    Freshour, Gary
    Tain, You-Lin
    Engels, Kevin
    Baylis, Chris
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (01) : F192 - F196